New federal disclosures revealed that 34 major pharmaceutical companies spent more than $120 million on lobbying last year, STAT reports.
The drugmakers, which include Pfizer, Johnson & Johnson and Merck, are members of PhRMA. According to the report, PhRMA broke its previous record on lobbying spend in 2019 with $28.9 million, up from $27.5 million in 2018.
According to the report, the pharmaceutical industry was able to keep at bay numerous legislative efforts to reduce drug prices.
To read the full report on STAT, click here.